Disclosures for "Rise of the Biologics: Shifting Prescribing Patterns for Neurosarcoidosis")
-
Dr. Lackey has nothing to disclose.
-
Dr. Veal has nothing to disclose.
-
Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Shah has received research support from Biogen. The institution of Dr. Shah has received research support from VeraSci.
-
The institution of Dr. Eckstein has received research support from Biogen. The institution of Dr. Eckstein has received research support from Genzyme.